Scientific analysis and scholar involvement are essential to the formation of physicians, but the variety of medical researchers has decreased over time. To implement corrective methods, the variables related to constructive analysis attitudes and productiveness amongst medical college students have to be recognized. The intention of this examine was to judge the variables related to college students or concerned in analysis. A validated questionnaire was utilized to the coed members of a longtime anatomy analysis group in a Mexican medical faculty with a six-year medical program. Information have been collected and analyzed.
A complete of 85.5% (n = 77/90) answered the survey with most respondents being second-year medical college students. An important element of conducting analysis was acknowledged to be contributing to new data (45.5%) and to the scientific group (42.9%) by most respondents. Greater than half point out a professor or a peer because the preliminary motivation to turn out to be concerned in analysis. Lack of time was the principle limitation (59.7%) to analysis involvement. Perceived advantages have been data and team-work expertise. Of these concerned, most (85.7%) wished to proceed collaborating in analysis as a complement to their medical work.
to focus on the principle attributes of Convergent Care Analysis that ratify it as a way of scientific analysis. Strategies: it’s a theoretical-reflective examine on Convergent Care Analysis’s theoretical-methodological assumptions. Improvement: Convergent Care Analysis is appropriate with the Social Constructionism paradigm. Convergent Care Analysis initiatives have two approaches: sensible and conceptual. The Convergent Care Analysis course of corpus incorporates 5 phases: conception; instrumentation; scrutiny; evaluation and theorizing.
Remaining Concerns: Convergent Care Analysis rigor encompasses the connection between analysis and care observe, and this corresponds to the convergence of those two dimensions. Attributable to its theoretical basis and standards of methodological rigor, Convergent Care Analysis is aligned with scientific analysis strategies. Professors and scholar colleagues have been discovered to play an necessary motivational and recruitment position for medical analysis. These efforts in flip will become mentor-mentee relationships. Early involvement in analysis as a scholar is anticipated to positively affect the probability of future physicians contribution and collaborating in analysis.
Small RNA analysis and the scientific repertoire: a story about biochemistry and genetics, crops and worms, improvement and illness
The invention of RNA interference in 1998 has made a long-lasting impression on organic analysis. Figuring out the regulatory position of small RNAs modified the modes of molecular organic inquiry in addition to biologists’ understanding of genetic regulation. This text examines the early years of small RNA biology’s success story. I question which elements needed to come collectively in order that small RNA analysis got here into life within the blink of a watch. I primarily take a look at scientific repertoires as facilitators of fast scientific change.
I present that for a brief time period, between the years 1998 and 2002, totally different mannequin organism communities, investigative methods, technological improvements, and analysis pursuits may very well be efficiently aligned to take small RNA analysis off the bottom. I talk about how the keystone discoveries have been located in particular experimental traditions and what methods have been employed to determine these discoveries as extra normal phenomena. Offering thus a practice-based strategy of fast scientific change, I ask learn how to relate the change in propositional bits of scientific data with modifications in scientific observe.
Evaluating affected person views on collaborating in scientific analysis and medical trials for the remedy of spinal wire damage
A questionnaire was developed to judge sufferers’ perspective on analysis geared toward bettering features and overcoming issues related to spinal wire damage (SCI). The primary three sections have been based mostly on revealed and validated evaluation instruments. The ultimate part was developed to evaluate participant views on analysis for SCI. One thousand sufferers have been approached, of which 159 participated. Fifty-eight % of members have been happy with their ‘life as an entire’. Two elements may very well be generated that mirrored the variance within the information concerning members’ life with a SCI: “Psychosocial and bodily wellbeing” and “Impartial residing”.
The vast majority of members acknowledged they’d be concerned in analysis (86%) or medical trials (77%). Nonetheless, the probability of participation dropped when potential dangers of the analysis/trials have been defined. Which members can be prepared to take part in analysis couldn’t be predicted based mostly on the severity of their damage, their psychosocial and bodily wellbeing or their unbiased residing. Regardless of participant institution of a life with SCI, our information signifies that people try for enhancements in perform. Participant willingness to be included in analysis research is noteworthy and scientists and clinicians are inspired to contain extra sufferers in all elements of their analysis.
Recombinant Thermobifida Fusca Cutinase(C-6xHis) |
|||
CR10-1mg | Novoprotein | 1mg | EUR 2486 |
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5. |
Recombinant Thermobifida Fusca Cutinase(C-6xHis) |
|||
CR10-500ug | Novoprotein | 500ug | EUR 1755 |
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5. |
Recombinant Thermobifida Fusca Cutinase(C-6xHis) |
|||
CR10-50ug | Novoprotein | 50ug | EUR 496 |
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5. |
pET- NLS- Cas9- 6xHis |
|||
PVT10639 | Lifescience Market | 2 ug | EUR 301 |
pET-dCas9-VP64-6xHis |
|||
PVT17702 | Lifescience Market | 2 ug | EUR 300 |
pET-6xHis-(-30)GFP |
|||
PVT17881 | Lifescience Market | 2 ug | EUR 341 |
pLenti-CARM1 shRNA-2 Plasmid |
|||
PVTBAV03691-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-CTLA4 shRNA-2 Plasmid |
|||
PVTBAV05689-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-FOXM1 shRNA-2 Plasmid |
|||
PVTBAV08732-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-JUN shRNA-2 Plasmid |
|||
PVTBAV11741-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-LHX6 shRNA-2 Plasmid |
|||
PVTBAV12881-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-MAGEA3 shRNA-2 Plasmid |
|||
PVTBAV13661-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-RUNX3 shRNA-2 Plasmid |
|||
PVTBAV20583-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-Slc7a11 shRNA-2 Plasmid |
|||
PVTBAV21973-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-STAT3 shRNA-2 Plasmid |
|||
PVTBAV22921-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-XRCC5 shRNA-2 Plasmid |
|||
PVTBAV26238-2 | Lifescience Market | 2 ug | EUR 356 |
Mouse Anti-6xHIS Tag monoclonal antibody |
|||
CABT-BL8767 | Creative Diagnostics | 100ug | EUR 559 |
pDONR223-CD73 Plasmid |
|||
PVTB00480-2 | Lifescience Market | 2 ug | EUR 356 |
Multi Fusion-Tagged recombinant Protein 52-Kda containing 16-tags (T-7, HSV, C-myc, VSV-G, Glu-Glu, V5, e-tag, Flag, S-tag, HA, KT3, E2, Au1, Au5, 6xHis-tags) for ELISA/Western |
|||
MFPM52-C | Alpha Diagnostics | 100 ul | EUR 286 |
Plasmid Midi Kit I |
|||
K1314-2 | Biovision | EUR 262 |
Plasmid Midi Kit II |
|||
K1315-2 | Biovision | EUR 262 |
Plasmid ezFilter Mega3 Kit |
|||
K1320-2 | Biovision | EUR 343 |
Plasmid ezFilter Mega6 Kit |
|||
K1321-2 | Biovision | EUR 370 |
Plasmid ezFilter Mega10 Kit |
|||
K1322-2 | Biovision | EUR 452 |
pCR4-TOPO-RNF135 Plasmid |
|||
PVTB01189-2 | Lifescience Market | 2 ug | EUR 356 |
pGEM-Ltf(Q25R) Plasmid |
|||
PVTB50084-2 | Lifescience Market | 2 ug | EUR 356 |
Monoclonal Anti-Poly-His (6xhis) (His-tag) IgG |
|||
HISP14-M | Alpha Diagnostics | 100 ug | EUR 482 |
ToxOut? Endofree Plasmid Midi Kit |
|||
K1328-2 | Biovision | EUR 207 |
ToxOut? Endofree Plasmid Maxi Kit |
|||
K1330-2 | Biovision | EUR 234 |
ToxOut? Endofree Plasmid Mega3 Kit |
|||
K1332-2 | Biovision | EUR 316 |
ToxOut? Endofree Plasmid Mega6 Kit |
|||
K1333-2 | Biovision | EUR 370 |
ToxOut? Endofree Plasmid Mega10 Kit |
|||
K1334-2 | Biovision | EUR 425 |
pMD19-T-LEO1(E225G) Plasmid |
|||
PVTB01141-2 | Lifescience Market | 2 ug | EUR 356 |
Plasmid ezFilter Midi Kit I, Centrifuge |
|||
K1316-2 | Biovision | EUR 262 |
Plasmid ezFilter Midi Kit II, Centrifuge |
|||
K1317-2 | Biovision | EUR 262 |
Express Plasmid Midiprep Kit (25 min) |
|||
K1323-2 | Biovision | EUR 262 |
Express Plasmid Maxiprep Kit (25 min) |
|||
K1324-2 | Biovision | EUR 283 |
ToxOut? Endofree ezFilter Plasmid Midi Kit |
|||
K1329-2 | Biovision | EUR 207 |
ToxOut? Endofree ezfilter Plasmid Maxi Kit |
|||
K1331-2 | Biovision | EUR 234 |
ToxOut? Express Endofree Plasmid Midi Kit |
|||
K1335-2 | Biovision | EUR 234 |
ToxOut? Express Endofree Plasmid Maxi Kit |
|||
K1336-2 | Biovision | EUR 262 |
pCDH-EF1-CymR-T2A-Puro (plasmid) |
|||
QM200PA-2 | SBI | 10 ug | EUR 597 |
pCDH-EF1-CymR-T2A-Neo (plasmid) |
|||
QM400PA-2 | SBI | 10 ug | EUR 581 |
Phospholipid transfer Antibody |
|||
20-abx110096 | Abbexa |
|
|
Monoclonal Anti-Poly-His (6xhis) (His-tag) antibody, ascites |
|||
HISP11-M | Alpha Diagnostics | 100 ul | EUR 482 |
Melanoma; Clone HMB45 (Concentrate) |
|||
A00019-C.2 | ScyTek Laboratories | 0.2 ml | EUR 236 |
2-Propyl-β-D-glucuronide, 2 mg |
|||
0904-2 | AthenaES | 2 mg | EUR 162 |
HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate) |
|||
RA0108-C.1 | ScyTek Laboratories | 0.1 ml | EUR 125 |
HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate) |
|||
RA0108-C.5 | ScyTek Laboratories | 0.5 ml | EUR 300 |
Mitomycin C |
|||
2713-2 | Biovision | EUR 120 |
Goat Anti-Poly-His (6xhis) (His-tag) IgG, aff pure |
|||
HISP16-A | Alpha Diagnostics | 100 ug | EUR 408 |
Goat Anti-Poly-His (6xhis) (His-tag) IgG-FITC conjugate |
|||
HISP16-FITC | Alpha Diagnostics | 100 ul | EUR 347 |
Rabbit Anti-Poly-His (6xhis) (His-tag) IgG-IR700DX conjugate |
|||
HISP17-IR7 | Alpha Diagnostics | 100 ul | EUR 408 |
IL-2 Interleukin-2 Human Recombinant Protein, His Tag |
|||
PROTP60568-2 | BosterBio | Regular: 10ug | EUR 317 |
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_ |
Rat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E02C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E03C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E03C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E03C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E08C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E08C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E08C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E06C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E06C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E06C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E04C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E04C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E04C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E07C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E07C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E07C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E02C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E02C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E01C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E01C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E01C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E09C0732-192T | BlueGene | 192 tests | EUR 1270 |
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E09C0732-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit |
|||
E09C0732-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer |
|||
PROTP12643-2 | BosterBio | Regular: 20ug | EUR 317 |
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques. |
PG LIVER 2 EA* |
|||
59423-2 | Pel-Freez | 2 EA | EUR 192.24 |
Individual Reaction Mix 2 |
|||
G065-2 | ABM | 200 reactions | EUR 167 |
Phospholipid transfer Antibody (Biotin) |
|||
20-abx105774 | Abbexa |
|
|
Phospholipid transfer Antibody (FITC) |
|||
20-abx107192 | Abbexa |
|
|
Phospholipid transfer Antibody (HRP) |
|||
20-abx108612 | Abbexa |
|
|
Phospholipid transfer Polyclonal Antibody |
|||
42297-100ul | SAB | 100ul | EUR 333 |
pCMV-C-HA-Bcl-2 Plasmid |
|||
PVTB00307-2c | Lifescience Market | 2 ug | EUR 356 |
Recombinant Human Relaxin-2 Protein |
|||
PROTP04090-2 | BosterBio | 25ug | EUR 317 |
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain. |
Recombinant Murine IL-2 Protein |
|||
PROTP04351-2 | BosterBio | 20ug | EUR 317 |
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues. |
Recombinant Human PAI-2 Protein |
|||
PROTP05120-2 | BosterBio | 10ug | EUR 317 |
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
Recombinant Human MMP-2 Protein |
|||
PROTP08253-2 | BosterBio | 10ug | EUR 317 |
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids). |
Recombinant Human BD-2 Protein |
|||
PROTO15263-2 | BosterBio | 20ug | EUR 317 |
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues. |
Anti-ErbB 2/ERBB2 Antibody |
|||
A00010-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Bcl-2/BCL2 Antibody |
|||
A00040-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Angiopoietin-2/ANGPT2 Antibody |
|||
A00370-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Fascin 2/FSCN2 Antibody |
|||
A07840-2 | BosterBio | 100ug/vial | EUR 294 |
Bovine KIDNEY WHOLE 2 EA* |
|||
57120-2 | Pel-Freez | 2 EA | EUR 174.84 |
Anti-EIF4A1/2/3 Antibody |
|||
A03922-2 | BosterBio | 100ug/vial | EUR 334 |
Mouse FGF-2 Recombinant Protein |
|||
R00121-2 | BosterBio | 5ug/vial | EUR 259 |
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast. |
Empirical analysis on the Gateway Perception Mannequin (GBM) has flourished lately. The mannequin presents a dual-process account of how perspective change occurs in response to normative cues about scientific settlement. A plethora of correlational and experimental proof has emerged documenting the constructive direct and oblique results of speaking the scientific consensus on international warming. I evaluation current scholarship and argue that the subsequent era of analysis on the GBM ought to deal with higher justifying the inclusion of moderators on each a theoretical and empirical degree, explicitly manipulate motivations to course of the consensus message, mannequin how consensus cues function in aggressive info networks and take a look at the mannequin in subject settings utilizing causal chain experiments.